M. A. MIR, M.B., M.R.C.P.; B. BRABIN, M.B., Ch.B.; O. T. TANG, M.B., M.R.C.P.; M. J. LEYLAND, M.R.C.P.; I. W. DELAMORE, Ph.D., F.R.C.P.E.
Potassium balance studies were carried out in 32 consecutive patients with acute myeloid leukaemia and its variants. Serum K level fell below 3.5 meq/litre in 19 (59%) of these patients at some stage of their illness. There was no correlation between urinary and serum lysozyme (muramidase) concentrations and the low serum K level. In addition to the unexplained urinary K loss, there appear to be other factors contributing to the development of hypokalaemia.
MIR MA, BRABIN B, TANG OT, et al. Hypokalaemia in Acute Myeloid Leukaemia. Ann Intern Med. 1975;82:54–57. doi: 10.7326/0003-4819-82-1-54
Download citation file:
Published: Ann Intern Med. 1975;82(1):54-57.
Endocrine and Metabolism, Fluid and Electrolyte Disorders, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use